Cancer Clinical Trial
Official title:
Tailored Intervention Protocol for Oral Chemotherapy Adherence
The primary aim of study is to:
1. Test the effectiveness of a tailored protocol in promoting adherence to oral
chemotherapeutic agents in adults receiving a new oral chemotherapeutic agent for
breast, colorectal, GIST, renal cell,and hepatocellular cancers.
Exploratory Aims:
2. Examine adherence to oral chemotherapeutic agents over time at 2, 4 and 6 months in a
sample of breast, colorectal, GIST, renal cell,and HPCC cancers patients.
3. Examine the effects of age, gender, caregiver availability, personal involvement in
health care, and depression on adherence to oral chemotherapeutic agents.
While cancer patients express a preference for oral medications, compliance to these
medications varies. Patients who successfully adhere to chemotherapy regimens have a greater
chance of non-recurrence and long-term quality of life. Thus, helping patients tolerate oral
chemotherapy regimens is critical to their survival. The aims of this study are to 1) test
the effectiveness of a tailored protocol to promote adherence to oral chemotherapeutic
agents in adults receiving treatment for cancer, 2) examine adherence to oral
chemotherapeutic agents over time, and 3) examine the effects of age, gender, caregiver
availability, personal involvement in health care, and depression on adherence rates to oral
chemotherapeutic agents.
The tailored adherence protocol is based on the self-regulatory model of adherence. The
intervention identifies patient knowledge, behavioral skills, and affective support and
tailors adherence strategies or overcomes barriers in each of these three categories. A
randomized clinical trial will examine the adherence rates in a 150 adults started on a new
oral chemotherapeutic agent. A control group will receive standard chemotherapy education.
Participants in the experimental group will receive the standard education, an assessment
and the tailored intervention developed by an advanced practice nurse. The intervention will
be administered via telephone calls over six months. Patient adherence rates will be
measured in both groups at 2, 4 and 6 months using self report, symptom profiles, and
pharmacy fill rates. To determine the effectiveness of the adherence protocol, we will use
Generalized Estimating Equations (with SAS), which provide a unified approach to
longitudinal modeling techniques for normally and non-normally distributed outcome
variables.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|